GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Net-Net Working Capital

Denis Chem Lab (BOM:537536) Net-Net Working Capital : ₹18.49 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Denis Chem Lab's Net-Net Working Capital for the quarter that ended in Mar. 2024 was ₹18.49.

The industry rank for Denis Chem Lab's Net-Net Working Capital or its related term are showing as below:

BOM:537536's Price-to-Net-Net-Working-Capital is ranked worse than
56.69% of 411 companies
in the Drug Manufacturers industry
Industry Median: 6.96 vs BOM:537536: 9.33

Denis Chem Lab Net-Net Working Capital Historical Data

The historical data trend for Denis Chem Lab's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Net-Net Working Capital Chart

Denis Chem Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.91 0.83 4.88 12.74 18.49

Denis Chem Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.74 - 15.10 - 18.49

Competitive Comparison of Denis Chem Lab's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's Price-to-Net-Net-Working-Capital falls into.



Denis Chem Lab Net-Net Working Capital Calculation

Denis Chem Lab's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Mar. 2024 is calculated as

Net-Net Working Capital(A: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(257.955+0.75 * 316.589+0.5 * 101.897-289.822
-0-0)/13.8767
=18.49

Denis Chem Lab's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2024 is calculated as

Net-Net Working Capital(Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(257.955+0.75 * 316.589+0.5 * 101.897-289.822
-0-0)/13.8767
=18.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Denis Chem Lab  (BOM:537536) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Denis Chem Lab Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines